Annual Reports in Medicinal Chemistry: Roadmaps, Volume 62 highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. This release provides a compendium of information on newly approved drugs and compounds entering late-stage clinical trials, making it a valuable resource for graduate students pursuing research in medicinal chemistry
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Preface - p. xi 8. Chapter One: The hybrid antimalarial approach: A roadmap: 2024 - p. 1 9. Chapter Two: The hybrid antimalarial approach - p. 42 10. Chapter Three: Antidiabetic natural products: Roadmap 2024 - p. 62 11. Chapter Four: Antidiabetic natural products - p. 113 12. Chapter Five: Future road map in neurodegenerative disease management with natural product: Roadmap 2024 - p. 151 13. Chapter Six: Neuroprotective natural products - p. 181 14. Chapter Seven: Roadmap for click and combinatorial approaches to quadruplex ligand discovery: 2024 - p. 223 15. Chapter Eight: Click and combinatorial approaches to quadruplex ligand discovery - p. 231 16. Chapter Nine: Current status and future directions of small-molecule quadruplex therapeutics in human cancer: Roadmap 2024 - p. 269 17. Chapter Ten: Challenges in developing small-molecule quadruplex therapeutics - p. 285
Annual Reports in Medicinal Chemistry: Roadmaps, Volume 62 highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. This release provides a compendium of information on newly approved drugs and compounds entering late-stage clinical trials, making it a valuable resource for graduate students pursuing research in medicinal chemistry
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Preface - p. xi 8. Chapter One: The hybrid antimalarial approach: A roadmap: 2024 - p. 1 9. Chapter Two: The hybrid antimalarial approach - p. 42 10. Chapter Three: Antidiabetic natural products: Roadmap 2024 - p. 62 11. Chapter Four: Antidiabetic natural products - p. 113 12. Chapter Five: Future road map in neurodegenerative disease management with natural product: Roadmap 2024 - p. 151 13. Chapter Six: Neuroprotective natural products - p. 181 14. Chapter Seven: Roadmap for click and combinatorial approaches to quadruplex ligand discovery: 2024 - p. 223 15. Chapter Eight: Click and combinatorial approaches to quadruplex ligand discovery - p. 231 16. Chapter Nine: Current status and future directions of small-molecule quadruplex therapeutics in human cancer: Roadmap 2024 - p. 269 17. Chapter Ten: Challenges in developing small-molecule quadruplex therapeutics - p. 285
